Global biosensors market is expected to reach USD 21.17 billion by 2020, according to a new study published by Grand View Research, Inc. Biosensors, owing to their capability to resolve various analytical issues in diverse areas such as medicine, pharmacology, food & agriculture safety and defense, are expected to witness a rapid growth in demand over the next six years.
Every odour has its own specific pattern which our noses are able to identify. Using a combination of proteins coupled to transistors, for the first time machines are able to differentiate smells that are mirror images of each other, so called chiral molecules, something that has not been possible before.
Research and Markets has announced the addition of the "Impact of Biosensing Technologies (Technical Insights)" report to their offering.
Known as much for its complexity as its vital role in regulating cellular and organismal growth, the mechanistic target of rapamycin complex 1 (mTORC1) pathway has seemingly been acting in mysterious ways.
Proteins and other bio molecules are often analysed exclusively in aqueous solutions in test tubes. But it is uncertain if these experimental studies can be transferred to the densely-packed cellular environment.
Researchers from North Carolina State University have found a way of binding peptides to the surface of gallium nitride (GaN) in a way that keeps the peptides stable even when exposed to water and radiation. The discovery moves researchers one step closer to developing a new range of biosensors for use in medical and biological research applications.
A cold 'sensor' which triggers the skin's vascular response to the cold could represent an exciting new therapeutic target for the treatment of frostbite and hypothermia, according to scientists at King's College London.
Driven by the ambitious objective to quickly detect the Ebola virus in the blood at a very early stage to minimize further transmission, STMicroelectronics and Clonit, in collaboration with Italy's National Institute for Infectious Diseases Lazzaro Spallanzani, have developed, in a few weeks' time, a prototype portable analyzer able to identify the presence of the Ebola virus in less than 75 minutes.
Valencell, a leader in performance biometric data sensor technology, today announced it is seeing a staggering demand from its licensees for highly accurate, clinically validated biometric technology. This demand, the Company revealed, is not solely coming from fitness and health sectors, but first responders/military and gaming industries as well.
Vital Connect announced today that its FDA-cleared wearable biosensor, HealthPatch® MD, is now available for use in clinical trials in partnership with Medidata, a leading global provider of cloud-based solutions for clinical research in life sciences. HealthPatch® MD can be used with Medidata’s industry-leading technology platform (Medidata Clinical Cloud®) and its mobile app for patient-reported outcomes (Medidata Patient Cloud®) to further remote patient monitoring, which has the potential to make clinical trials more efficient.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.